Founder / Karam Bioscience
Build beyond
the obvious.
A founder taking on cellular aging, the physics of fields, water in the atmosphere, and what a human life can leave behind.
The founder / Direction & discovery
What becomes possible when we stop treating biology, physics and engineering as separate worlds?
Christopher Hill is the founder of Karam Bioscience, MaxwellX, Weatherhill and Death X. Each venture starts with a different question. Together, they reflect his interest in how living and physical systems work—and what it would take to change them.
At Karam, the ambition is to keep cells healthy and restore useful function where possible. At MaxwellX, it is to turn field physics into measurable systems. Weatherhill takes those questions into fog, water and visibility. Death X asks what can be preserved from a life, and what future research might make of it.
His contribution is to set direction, connect ideas across disciplines, develop research programs and build the tools around them. His background in business development and digital products shapes the next question: how does a promising idea become something another person can use?
Follow the work, not just the biographyThe portfolio / Founded by Christopher Hill
Different disciplines. Distinct programs.
Explore each venture on its own terms.
Cellular health, aging and functional restoration. Karam connects a research Atlas, analytical tools and proposed study programs to a practical question: what would show that a cell works better, not merely looks younger on a test?
MaxwellX explores how geometry, electromagnetic fields, boundaries, materials and light shape energy transfer. FieldLab gives that agenda a defined experimental direction, with modeling and measurement at its core.
Weatherhill investigates fog collection, optical visibility and atmospheric water. Its planned FogLab instrument is the first proving ground. Airport and infrastructure programs connect the research to the decisions operators need to make.
Death X is developing a biological and digital archive concept: DNA, selected living cells and the original records of a life. Its research agenda explores preservation, neural models and future representations without treating an archive as proof of continued consciousness.
Connected through their founder; each venture has its own scope and development stage. Links do not imply shared clinical approvals or completed experimental results.
Selected contributions / Public work
Research direction, accessible knowledge and tools built around consequential questions. Start with something you can inspect.
Karam / Research platform
The Karam platform brings together a filterable evidence Atlas, source-linked study briefs and 14 research and planning tools. The tools cover experimental comparisons, study budgets, measurement and project scoping.
Weatherhill / Public scientific resources
Weatherhill’s public site lists 280 papers and preprints across 11 research fields, alongside 15 optics, airflow, energy and experimental-design tools. The collection supports the proposed FogLab program and its next measurements.
Death X / Preservation research
The Death X edition lists 138 explained source records across 19 field guides. Its Archive specification addresses biological material, original life records, consent and custody as separate requirements within one proposed program.
MaxwellX / Research direction
The MaxwellX agenda connects geometry, fields, light and materials to instrument concepts and an energy-transfer test program. Its public FieldLab outline sets out the baseline, changed geometry, readouts and repetition needed to examine a physical signature.
Karam / Development pathways
Eight proposed project briefs connect cellular-state benchmarks, senescence measurement, CRISPR data, cell mechanics and evidence systems to explicit work packages. Product scopes link that work to research teams, laboratories and development partners.
Portfolio snapshot: 15 October 2026. External library totals are the ventures’ published counts. They describe curated work from its original authors—not scientific papers authored by Christopher Hill. AI-assisted knowledge resources, software and program plans are distinct from independently validated experimental findings.
The next chapter
The ambition is not another description of the future.
It is a path toward building something useful.
AI concept artwork / Not an operating Karam laboratory
How the work moves forward
Christopher’s role is to connect the scientific question, the right people and the practical requirements of the next step.
A cell losing function. An airfield losing visibility. A physical effect no instrument captures well enough. Begin with the consequence, not the pitch.
Define the comparison, the measurement and the result that would change the plan. Seek specialist judgment where the work requires it.
A tool, a study, a clearer decision or a better experiment. The next deliverable should do more than make the story sound impressive.
A personal influence / John Harvey Karam, MD
Christopher names his uncle, John Harvey Karam, MD, as a formative influence. A UCSF physician-scientist and teacher, Dr. Karam connected diabetes research with patient care and a commitment to sharing knowledge.
The example Christopher carries forward is personal: take the science seriously, treat people with dignity, and remember who the work is for.
The historical achievements are Dr. Karam’s. No UCSF appointment or institutional endorsement of Christopher or his ventures is implied. Image: speculative concept artwork.
Build with Karam
Research teams, instrument builders, laboratory partners and people with a result worth examining: start with the work, the evidence and the next step you think matters.
Christopher Hill is the founder of Karam Bioscience, MaxwellX, Weatherhill and Death X. His work connects research direction, public knowledge resources, digital tools and venture development across cellular health, field physics, atmospheric water and biological preservation. At Karam, he is developing a research initiative focused on cellular aging and functional restoration. Across the ventures, he sets priorities, develops program concepts and seeks the specialist collaborators needed to turn difficult questions into useful work.
This profile describes founder roles and public work, using the venture websites and the Karam site’s own inventory. Source notes distinguish public tools and knowledge resources from proposed research and experimental results. Research indexed by the ventures remains credited to its original authors.
Reviewed 15 October 2026. The first-party profiles establish how the ventures describe the founder’s role; they are not independent scientific recognition. The four images are AI-generated concepts, including a fictional android portrayal—not photographs, real facilities or evidence of human rejuvenation.
Karam’s new CRISPR section turns cellular-restoration questions into evidence records, research programs, project briefs and scoped service inquiries. The biological work remains qualification-dependent; the public Atlas and planning tools are available to inspect.
Explore the CRISPR section